Associate Professor, Medicine, Tufts Medical Center
Oncology
Dr. Robert E. Martell, MD
|
|
Give Review
Robert Martell practices Oncology. He researched medicine at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care Robert Martell is a published doctor as well. He has 23 publications published. The latest was: Iodoaryl analogues of dioctanoylglycerol and 1-oleoyl-2-acetylglycerol as probes for protein kinase C. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid Tumors.
- Diabetes, metformin use, and colorectal Cancer survival in postmenopausal women.
- Discovery of novel drugs for promising targets.
- Oncology drug development and approval of systemic antiCancer therapy by the u.s. Food and drug administration.
- Mocetinostat for relapsed classical Hodgkin's Lymphoma: an open-label, single-arm, phase 2 trial.
- Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in Leukemia.
- Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay.
- Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid Tumors.
- A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in p...
- Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid Tumors.
- A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced Cancer.
- Optimizing aptamer activity for gene therapy applications using expression cassette SELEX.
- Comprehensive assessment of the elderly Cancer patient: the feasibility of self-report methodology.
- Iodoaryl Analogues of dioctanoylglycerol and 1-oleoyl-2-acetylglycerol as probes for protein kinase C.
- Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tu...
- Reconstitution of dna synthetic capacity in senescent normal human fibroblasts by expressing cellular factors E2F and Mdm2.
- Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic Leukemia: Intergroup Study Cancer...
- Therapeutic enhancement of IL-2 through molecular design.
- Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocyt...
- The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin Lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.
- Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia.
- Histone deacetylase inhibitors in Cancer therapy: new compounds and clinical update of benzamide-type agents.
Schools
Wayne State University
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Duke University Hospital -
Wayne State University School of Medicine
Hospital
-
Tufts Medical Center
Drug Facts
| NPI NUMBER | 1477788099 | |
| NPPES Provider LastName | MARTELL | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 021111552 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 37.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477788099 |
| Last Name Of The Provider | MARTELL |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
Dr. Gabriel A. Brooks, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eliezer M. VanAllen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia H. Hayes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth I. Buchbinder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Abrams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy P. Cooley, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kevin Chin, MD
This Doctor is OpenDoctor Recommended.
|